Production (Stage)
Harvard Apparatus Regenerative Technology Inc.
HRGN
$1.66
-$0.14-7.78%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 161.25% | 317.48% | 487.50% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 161.25% | 317.48% | 487.50% | -- | -- |
| Cost of Revenue | 708.33% | 1,025.00% | 715.38% | -- | -- |
| Gross Profit | 2.42% | 102.53% | 377.78% | -- | -- |
| SG&A Expenses | 1.58% | -15.40% | -7.20% | 4.89% | 0.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.96% | -15.80% | -8.87% | -5.13% | 22.24% |
| Operating Income | 15.37% | 19.62% | 11.16% | 7.80% | -19.88% |
| Income Before Tax | 8.95% | 13.56% | 4.64% | 1.07% | -19.14% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.95% | 13.56% | 4.64% | 1.07% | -19.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.95% | 13.56% | 4.64% | 1.07% | -19.14% |
| EBIT | 15.37% | 19.62% | 11.16% | 7.80% | -19.88% |
| EBITDA | 15.19% | 19.46% | 10.95% | 7.54% | -20.34% |
| EPS Basic | 16.25% | 22.22% | 15.72% | 14.48% | 2.35% |
| Normalized Basic EPS | 22.33% | 26.69% | 19.26% | 17.24% | -1.42% |
| EPS Diluted | 16.25% | 22.22% | 15.72% | 14.48% | 2.35% |
| Normalized Diluted EPS | 22.33% | 26.69% | 19.26% | 17.24% | -1.42% |
| Average Basic Shares Outstanding | 10.04% | 9.94% | 10.64% | 13.42% | 18.60% |
| Average Diluted Shares Outstanding | 10.04% | 9.94% | 10.64% | 13.42% | 18.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |